The Official Newsletter of
THE EUROPEAN SCIENTIFIC
COOPERATIVE ON PHYTOTHERAPY
ISSUE 1
Including selected proceedings of the 5th International ESCOP Symposium
Phytomedicine and Consumer Protection
QEII Conference Centre, London
15-16th October 1998
|
This first issue of The European Phytojournal is complete.
All articles have been paginated as one volume for citation purposes. All are downloadable
pdf files (portable document format) and to read them you will require Adobe Acrobat
Reader, available by clicking on the icon to the right. There are also other downloadable
materials, not formally in the first issue, that will require different programs.
|
 |
 |
Regulatory
perspectives |
European Commission DG XXIV
(Consumer policy and health protection)
Dr Marina Manfredi, Director for Consumer Policy
European Agency for the
Evaluation of Medicinal Products (EMEA)
Dr Rolf Bass, Head, Human Medicines Evaluation Unit
EMEA ad hoc Working Group on
Herbal Medicinal Products
Dr Konstantin Keller, Chairman
Medicines Control Agency (MCA)
Mr Roy Alder, Head, Policy Unit
The European Proprietary
Medicine Manufacturers Association (AESGP)
Dr Hubertus Cranz, Director
|
Analytical
standards |
Pharmacopoeial standards for
herbal medicinal products in Europe
Dr Agnès Artiges, Director, European Pharmacopoeia
|
Quality and
safety issues |
Approaches to the quality
characterisations of medicinal plant derivatives
Professor Bombardelli, Scientific Board, Indena, Milan (Slides for above)
Interactions of herbal with
other medicines
Professor David Phillipson, School of Pharmacy, University of London
The attitudes of the herbal
consumer: a survey
Jo Barnes, University of Exeter
|
Efficacy and
safety |
St. John’s wort and
depression
Dr Trautmann-Sponsel, Karlsruhe
Clinical trials in
phytotherapy: from concept to publication
Dr Anne Walker, University of Reading
The ESCOP monographs
Dr Barbara Steinhoff, co-Secretary, ESCOP Scientific Committees
|
Posters |
Randomised Placebo-Controlled
double-blind Clinical Trial of a Special Extract of Kava Roots (WS 1490) in Patients with
Anxiety Disorders of Non-psychotic Origin
U. Malsch, S. Klement
Controlled post-marketing
surveillance studies - an innovative design for evaluating clinical effectiveness
E. Ernst
RP-HPLC Analysis for Active
Constituents in "Yin Qiao Du" Tablets
Xudong Yuan and Wai-Keung Chui
Long-term Effect of Garlic in
Preventing Arteriosclerosis - Results of Two Controlled Clinical Trials
G. Siegel
LC-MS Analysis and Biological
Activities of Steroid Saponins in Garlic
Hiromichi Matsuura
Efficacy and Safety of Ginkgo
Biloba Special Extract EGb 761¨ in the Acute Treatment of Well-defined Diseases
D.Loew
Human pharmacological
investigations during treatment of climacteric complaints with Cimicifuga racemosa
(Remifemin): no estrogen-like effects
E.Liske, P.WŸstenberg, N. Boblitz
Traditional Chinese Herbal
Medicine: The Development of an Authentication Centre for Europe
Leon CJ, Simmonds M and Shaw D
Peppermint oil for irritable
bowel syndrome: a critical review and meta-analysis
Pittler MH, Ernst E
|
Appendix |
1) Additional web based
material
| The following material is provided as
Microsoft Word and
Microsoft Powerpoint files. Users who do not have the full versions of these Microsoft products can
download viewer software from Microsoft's website. |
 |
Clinical studies of ginseng.
Summary in Word format &
Powerpoint
Presentation by Dr Riccardo Faleni, Pharmaton SA, Lugano
Return to European
Phytojournal contents
|
